Ajanta Pharma reports 76% surge in Q3 net profit

Ajanta Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532331 | NSE: AJANTPHARM

23 Jan 2013 Evaluate

Ajanta Pharma has reported results for third quarter ended December 31, 2012.

The company has registered a rise of 75.96% in its net profit at Rs 32.57 crore in Q3FY13 as compared to Rs 18.51 crore in the corresponding quarter previous year. The total income from operation of the company has increased by 39.65% to Rs 229.34 crore for the quarter under review as compared to Rs 164.23 crore in the same quarter last year.

Ajanta Pharma (APL) is engaged manufacturing pharmaceutical products. The company runs three divisions -- prescription drugs, OTC and institutional sales.

Peers

Company Name	CMP
Sun Pharma. Inds.	1866.00
Dr. Reddys Labs.	1172.05
Cipla	1372.25
Lupin	2092.00
Zydus Lifesciences	1137.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.